ARTICLE | Finance
New entrants swelling Hong Kong IPO queue: Finance Report
Eight companies file on HKSE, plus two seek dual listings; NASDAQ’s Ocular, Ovid, Palisade also raise; and VCs back Crystalys, Star, Cartography
October 3, 2025 10:32 PM UTC
The market for new biotech listings in Hong Kong had been gaining momentum during the third quarter, and the past week has delivered a wave of filings that fattened the IPO queue going into 4Q25.
Since Sept. 26, eight life sciences companies have filed for IPOs on the Hong Kong Stock Exchange, along with two more listed elsewhere in China. The burst in activity preceded an Oct. 1 National Day holiday; trading on the exchange will also be halted for the Mid-Autumn Festival holiday on Oct. 7...